Retrieve available abstracts of 51 articles: HTML format
Single Articles
August 2025
FAN Z, Li J, He L, Li Q, et al Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via
site-specific microbial transglutaminase labeling.
Biochem Biophys Res Commun. 2025;775:152162. PubMedAbstract available
June 2025
PERFILOVA KV, Matyuta IO, Minyaev ME, Boyko KM, et al High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2
nucleoprotein variant with improved replicative fitness.
Biochem Biophys Res Commun. 2025;767:151915. PubMedAbstract available
KOU L, Wan Y, Nemoto YL, Tsujita K, et al Role of membrane proximal actin regulators in SARS-CoV-2 spike-induced cell-cell
fusion.
Biochem Biophys Res Commun. 2025;766:151846. PubMedAbstract available
CHU X, Yang Y, Guo H, Ji X, et al SARS-CoV-2 NSP2 specifically interacts with cellular protein SmgGDS.
Biochem Biophys Res Commun. 2025;764:151828. PubMedAbstract available
ZHANG YH, Su AM, Hou XM Structural and functional insights into the SARS-CoV-2 SUD domain and its
interaction with RNA G-Quadruplexes.
Biochem Biophys Res Commun. 2025;764:151817. PubMedAbstract available
April 2025
LIU HL, Lin S, Hung W, Chang DC, et al A novel replicase-mediated self-amplifying RNA amplification mechanism of the
SARS-CoV-2 replication-transcription system.
Biochem Biophys Res Commun. 2025;758:151654. PubMedAbstract available
ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al Corrigendum to "mRNA encoding antibodies against hemagglutinin and nucleoprotein
prevents influenza virus infection in vitro" [Biochem. Biophys. Res. Commun. 738
(2024) 150945].
Biochem Biophys Res Commun. 2025 Apr 9:151783. doi: 10.1016/j.bbrc.2025.151783. PubMed
GU L, Wang ZJ, Zhang XR, Liu Y, et al Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the
replication of SARS-CoV-2 strains.
Biochem Biophys Res Commun. 2025;756:151594. PubMedAbstract available
KOCHAROVSKAYA MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, et al Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab
of neutralizing antibody REGN10987.
Biochem Biophys Res Commun. 2025;755:151558. PubMedAbstract available
March 2025
IMBIAKHA B, Ezzatpour S, Buchholz DW, Poosala S, et al Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2
infection in mice.
Biochem Biophys Res Commun. 2025;753:151480. PubMedAbstract available
February 2025
DU S, Yang L, Chen X, Chen Y, et al Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2
variants.
Biochem Biophys Res Commun. 2025;746:151224. PubMedAbstract available
January 2025
CULIAT C, Soni D, Malkes W, Wienhold M, et al NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune
response, and the HIF-1alpha hypoxia pathway to promote healing in viral-induced lung
injury.
Biochem Biophys Res Commun. 2025;744:151198. PubMedAbstract available
December 2024
HOSOKAWA K, Ohmori H Digital reverse transcription PCR using a simple poly(dimethylsiloxane) microwell
array chip for detection of SARS-CoV-2.
Biochem Biophys Res Commun. 2024;741:151070. PubMedAbstract available
ROY A, Paul I, Paul T, Dihidar A, et al Exploring B-cell epitope conservation and antigenicity shift in current COVID-19
variants: Analyzing spike-antibody interactions for therapeutic uses.
Biochem Biophys Res Commun. 2024;739:150948. PubMedAbstract available
BEGUM F, Chandra S, Mallik MH, Dey J, et al A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a
high-density repetitive manner on a virus-like particle could generate
anti-SARS-CoV-2 neutralizing antibodies unlike free peptide.
Biochem Biophys Res Commun. 2024;739:150579. PubMedAbstract available
ZHAN Y, Li M, Gong R Protein mimics of fusion core from SARS-CoV-1 can inhibit SARS-CoV-2 entry.
Biochem Biophys Res Commun. 2024;736:150857. PubMedAbstract available
November 2024
SINGH V, Bhutkar M, Choudhary S, Nehul S, et al Structure-guided mutations in CDRs for enhancing the affinity of neutralizing
SARS-CoV-2 nanobody.
Biochem Biophys Res Commun. 2024;734:150746. PubMedAbstract available
ZUBIETE-FRANCO I, Tonks NK Famotidine increases cellular phospho-tyrosine levels.
Biochem Biophys Res Commun. 2024;734:150763. PubMedAbstract available
VISSAPRAGADA M, Addala S, Aggunna M, Sodasani M, et al Leveraging the potential of bacterial lateral gene transfer in boosting the
efficacy of an edible probiotic prototype yogurt vaccine for COVID-19.
Biochem Biophys Res Commun. 2024;734:150622. PubMedAbstract available
UCHIKUBO-KAMO T, Ishimoto N, Umezawa H, Hirohama M, et al Structural insights into Influenza A virus RNA polymerase PB1 binding to nuclear
import host factor RanBP5.
Biochem Biophys Res Commun. 2024;739:150952. PubMedAbstract available
ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents
influenza virus infection in vitro.
Biochem Biophys Res Commun. 2024;738:150945. PubMedAbstract available
September 2024
KUSHWAHA N, Dwivedi A, Tiwari S, Mishra P, et al Comprehensive analytics for virus-cell and cell-cell multinucleation system.
Biochem Biophys Res Commun. 2024;726:150281. PubMedAbstract available
LI Q, Zhou X, Wang W, Xu Q, et al Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main
protease.
Biochem Biophys Res Commun. 2024;724:150230. PubMedAbstract available
XU J, Zhu Q, Li W, Yin X, et al Structural basis for the inhibition of the HCoV-NL63 main protease M(pro) by X77.
Biochem Biophys Res Commun. 2024;724:150231. PubMedAbstract available
July 2024
TACHIBANA K, Nakamura Y, Do TL, Kihara T, et al Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity
during the development of Omicron pandemic variants.
Biochem Biophys Res Commun. 2024;719:150120. PubMedAbstract available
GAUR NK, Urankar S, Sengupta D, Chepuri VR, et al A cell based assay using virus-like particles to screen AM type mimics for
SARS-CoV-2 neutralisation.
Biochem Biophys Res Commun. 2024;718:150082. PubMedAbstract available
KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits
SARS-CoV-2 entry into Vero E6 cells.
Biochem Biophys Res Commun. 2024;716:149954. PubMedAbstract available
June 2024
BAI G, Zeng X, Zhang L, Wang Y, et al Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2
accessory protein ORF3b.
Biochem Biophys Res Commun. 2024;712-713:149945. PubMedAbstract available
KAWAI A, Hirata H, Tokunoh N, Ono C, et al Adjuvant-free parenterally injectable vaccine platform that harnesses previously
induced IgG as an antigen delivery carrier.
Biochem Biophys Res Commun. 2024;711:149919. PubMedAbstract available
May 2024
KALASHNYK O, Lykhmus O, Sullivan R, Komisarenko S, et al Agonists or positive allosteric modulators of alpha7 nicotinic acetylcholine receptor
prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
Biochem Biophys Res Commun. 2024;709:149825. PubMedAbstract available
SU L, Lou Y, Li J, Mao H, et al Influence of storage solution, temperature, assay time and concentration on
RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the
RT-qPCR.
Biochem Biophys Res Commun. 2024;707:149726. PubMedAbstract available
April 2024
KOMU JG, Jamsransuren D, Matsuda S, Ogawa H, et al Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic
samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced
biosafety and viral genome preservation.
Biochem Biophys Res Commun. 2024;715:149994. PubMedAbstract available
March 2024
HE K, Ye Y, Liu S, Yuan P, et al Polylevodopa nanoplatform for lateral flow immunochromatography assay of
SARS-CoV-2 and influenza A virus.
Biochem Biophys Res Commun. 2024;709:149821. PubMedAbstract available
KIM HJ, Han CW, Jeong MS, Jang SB, et al Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR
complex.
Biochem Biophys Res Commun. 2024;706:149728. PubMedAbstract available
January 2024
SAITO T, Couzinet A, Murakami T, Shimomura M, et al Rapid and high throughput assessment of cellular immunity against SARS-CoV-2
based on the ex vivo activation of genes in leukocyte assay with whole blood.
Biochem Biophys Res Commun. 2024;694:149398. PubMedAbstract available
NASSAR K, El-Mekawey D, Elmasry AE, Refaey MS, et al The significance of caloric restriction mimetics as anti-aging drugs.
Biochem Biophys Res Commun. 2024;692:149354. PubMedAbstract available
JIANG H, Zou X, Zhou X, Zhang J, et al Crystal structure of SARS-CoV-2 main protease (M(pro)) mutants in complex with
the non-covalent inhibitor CCF0058981.
Biochem Biophys Res Commun. 2024;692:149352. PubMedAbstract available
December 2023
KAWAHARA E, Yamamoto S, Shibata T, Hirai T, et al CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial
virus infection in the upper respiratory tract via CD4(+) T cells.
Biochem Biophys Res Commun. 2023;686:149143. PubMedAbstract available
ZHANG L, Zhang X, Deng X, Wang P, et al Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal
transition in COVID-19 lung fibrosis.
Biochem Biophys Res Commun. 2023;686:149118. PubMedAbstract available
November 2023
CARONIA L, Xi R, Margolskee RF, Jiang P, et al Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by
nirmatrelvir.
Biochem Biophys Res Commun. 2023;682:138-140. PubMedAbstract available
October 2023
JIANG S, Yang H, Sun Z, Zhang Y, et al The basis of complications in the context of SARS-CoV-2 infection: Pathological
activation of ADAM17.
Biochem Biophys Res Commun. 2023;679:37-46. PubMedAbstract available
FRASER-PITT D, Mercer DK, Francis ML, Toledo-Aparicio D, et al Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial
cell inflammatory and innate immune responses to viral infection.
Biochem Biophys Res Commun. 2023;677:168-181. PubMedAbstract available
YAO Y, Zhang Y, Li Z, Chen Z, et al A deep learning-based drug repurposing screening and validation for
anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
Biochem Biophys Res Commun. 2023;675:113-121. PubMedAbstract available
September 2023
FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved
antigen detection.
Biochem Biophys Res Commun. 2023;673:114-120. PubMedAbstract available
August 2023
SUN W, Zhang Z, Chen M, Liu X, et al Discovery of a potent inhibitor targeting the cap-binding domain of the PB2
subunit of influenza RNA-dependent RNA polymerase.
Biochem Biophys Res Commun. 2023;678:97-101. PubMedAbstract available
YU J, Im H, Lee G Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca(2+),
elucidated by biochemical and single-molecular studies.
Biochem Biophys Res Commun. 2023;668:35-41. PubMedAbstract available
July 2023
BEAUDOIN CA, Petsolari E, Hamaia SW, Hala S, et al SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
Biochem Biophys Res Commun. 2023;666:61-67. PubMedAbstract available
June 2023
ISHII H, Jounai K, Tsuji R, Ohshio K, et al Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma
produce soluble factors to suppress SARS-CoV-2 replication.
Biochem Biophys Res Commun. 2023;662:26-30. PubMedAbstract available
CHU X, Ding X, Yang Y, Lu Y, et al Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing
SARS-CoV-2.
Biochem Biophys Res Commun. 2023;660:43-49. PubMedAbstract available
May 2023
ITO K, Goto K, Shirakawa R, Horiuchi H, et al Platelet alphaIIbbeta3 integrin binds to SARS-CoV-2 spike protein of alpha strain but
not wild type and omicron strains.
Biochem Biophys Res Commun. 2023;657:80-85. PubMedAbstract available
ZHOU Y, Wang W, Zeng P, Feng J, et al Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814
and PF-07321332.
Biochem Biophys Res Commun. 2023;657:16-23. PubMedAbstract available